Academic literature on the topic 'Agenți anticancer'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Agenți anticancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Agenți anticancer"

1

Ana, LEORDA, and TOLSTENCO Dorina. "ROLUL PLANTELOR MEDICINALE ONCOPROTECTOARE ȘI AL REMEDIILOR PE BAZA LOR ÎN TERAPII ANTICANCER." STUDIA UNIVERSITATIS MOLDAVIAE Științe Reale și ale Naturii, no. 6(156) (2022): 53–59. https://doi.org/10.5281/zenodo.7442397.

Full text
Abstract:
&Icirc;n articol au fost elucidate unele mecanisme de acțiune relevante ale plantelor medicinale oncoprotectoare și ale<strong> re&shy;me&shy;diilor pe baza lor</strong> &icirc;n terapii complementare anticancer. Av&acirc;nd &icirc;n vedere efectele secundare, toxicitatea și costurile mari, inerente terapiilor anticancer tradiționale, răm&acirc;ne a fi actuală identificarea de noi compuși din surse naturale, inclusiv plante medicinale sigure și eficiente &icirc;mpotriva chimiorezistenței și &icirc;mpotriva cancerului, ceea ce oferă perspective pro&shy;mi&shy;țătoare &icirc;n tratarea acestei m
APA, Harvard, Vancouver, ISO, and other styles
2

K., Gandhi Mansi, and Dr Shashi V. Ranga. "Insights into Quinoline Schiff Bases as Anticancer Agents." International Journal of Research Publication and Reviews 5, no. 11 (2024): 526–38. http://dx.doi.org/10.55248/gengpi.5.1124.3116.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dikusar, E. A. "Quantum chemical designing of cholesterol containing radionuclide anticancer agents." Functional materials 23, no. 2 (2016): 274–78. http://dx.doi.org/10.15407/fm23.02.274.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

El-Sayed, Ashraf S. A., Manal T. El Sayed, Hend S. Nada, Abdallah E. Hassan, and Eman K. Yousef. "Production and Characterization of Taxol as Anticancer Agent from Aspergillus terreus." Journal of Pure and Applied Microbiology 13, no. 4 (2019): 2055–63. http://dx.doi.org/10.22207/jpam.13.4.17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kundu, Nilesh. "Copper Nanoparticles as Emerging Anticancer Agents: Mechanistic Insights, Therapeutic Potential, and Future Perspectives." International Journal of Research Publication and Reviews 6, no. 5 (2025): 7912–20. https://doi.org/10.55248/gengpi.6.0525.1807.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mankhi, Rusul Naeim, and Nabeel A. Abdul-Rida. "NEW FENOFIBRATE DERIVATIVES AS ANTICANCER AND ANTIOXIDANT AGENTS: SYNTHESIS, IN SILICO STUDY AND BIOLOGICAL EVALUATION." Chemical Problems 23, no. 2 (2025): 286–93. https://doi.org/10.32737/2221-8688-2025-2-286-293.

Full text
Abstract:
Fenofibrate is a medication derived from fibric acid that is used to treat severe cases of high triglyceride levels and a combination of abnormal lipid levels in individuals who have not shown improvement with nonpharmacological treatments. As part of this research, novel classes of Fenofibrate derivatives were synthesized and evaluated in vitro as anticancer and antioxidant agents. Spectroscopic techniques, including infrared, NMR and elemental analysis, were used to validate their structures conclusively. all products were screened in vitro against cell lines MDA-MB-231. The cytotoxicity ass
APA, Harvard, Vancouver, ISO, and other styles
7

Abdul-Rida, Nabeel A., and Kawther M. Talib. "NEW CHALCONE DERIVATIVES AS ANTICANCER AND ANTIOXIDANT AGENTS: SYNTHESIS, MOLECULAR DOCKING STUDY AND BIOLOGICAL EVALUATION." Chemical Problems 22, no. 2 (2024): 177–86. http://dx.doi.org/10.32737/2221-8688-2024-2-177-186.

Full text
Abstract:
In this approach, a series of new chalcone derivatives bearing baclofen drug were synthesized via Claisen-Schmidt condensation and evaluated in vitro as anticancer and antioxidant agents. The newly synthesized compounds were characterized by FT-IR, 1H-NMR, 13C-NMR spectra, and elemental analysis. All products were screened in vitro against both cell lines HdFn and MCF-7. The cytotoxicity assay results revealed that derivatives 5a and 5d exhibited good inhibition for cell lines MCF-7 with IC50 values 32.5 and 37.6 µM, respectively while 5a and 5c exhibited acceptable inhibition for HdFn with IC
APA, Harvard, Vancouver, ISO, and other styles
8

C.A, Mbah, Okonkwo S.C, Nwaume E.J, Olawoore F.R, and Abah E.I. "Traditional African Medicinal Plants as Potential Sources of Anticancer Agents: Bioactive Compounds, Mechanisms, and Future Directions." International Journal of Research Publication and Reviews 6, no. 5 (2025): 11679–91. https://doi.org/10.55248/gengpi.6.0525.18121.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Yashwant, B.Srivastava, K. Sharma Brij, and Gaur Kalpesh. "A Probable Target for Novel Anticancer Agents: Cdc25 Phosphatases as Cyclin-Dependent Kinase Inhibitors." International Journal of Current Pharmaceutical Review and Research 1, no. 1 (2010): 76–82. https://doi.org/10.5281/zenodo.12699668.

Full text
Abstract:
There are many different types of cancer, but all share a common feature &ndash; rapid anduncontrolled cell proliferation. Emergence of new tumors is associated with mutations orabnormalities in expression of various cell cycle regulators like cyclins and cyclindependent kinases (Cdk). Cell Division Cycle 25 (Cdc25) Phosphatases are DualSpecificity Phosphatases (DSP) that dephosphorylate and activate the Cdk/cyclincomplexes, thereby playing a fundamental role in transitions between cell cycle phases.&nbsp;
APA, Harvard, Vancouver, ISO, and other styles
10

Ali, M. M., M. M. Ramadan, K. Z. Ghanem, and A. H. El-Ghorabe. "Essential oils from Egyptian aromatic plants as antioxidant and novel anticancer agents in human cancer cell lines." Grasas y Aceites 66, no. 2 (2015): e080. http://dx.doi.org/10.3989/gya.0955142.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Agenți anticancer"

1

Hudnott, Anna Ruth. "Bioreductive anticancer agents." Thesis, University of Exeter, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.302640.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pettersson, Hanna Ilse. "Quinolinequinones as anticancer agents." Thesis, University of Exeter, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.249038.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Braña, García Irene. "Anticancer targeted agent combination." Doctoral thesis, Universitat Autònoma de Barcelona, 2017. http://hdl.handle.net/10803/457506.

Full text
Abstract:
Las toxicidades limitantes de dosis fuero una neutropenia febril grado 4 (en el brazo de docetaxel) y una neutropenia grado 3 en el brazo de gemcitabina. La combinación de carlumab no tuvo un impacto El cáncer es una enfermedad altamente frecuente y con alta mortalidad. El desarrollo de fármacos contra el cáncer se ha caracterizado por su ineficiencia, con una de las tasas de aprobación de fármacos más baja entre las diferentes especialidades médicas. El principal motivo de esta baja tasa de éxito es la falta de eficacia de los nuevos fármacos que entran al desarrollo clínico. Se han plantea
APA, Harvard, Vancouver, ISO, and other styles
4

Fryatt, Tara. "Quinolinequinones as bioreductive anticancer agents." Thesis, University of Exeter, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.302535.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

McKeown, Paul. "Synthesis of novel anticancer agents." Thesis, University of Glasgow, 1996. http://theses.gla.ac.uk/7016/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Magri, Neal Francis. "Modified taxols as anticancer agents." Diss., Virginia Polytechnic Institute and State University, 1985. http://hdl.handle.net/10919/53892.

Full text
Abstract:
Modifications of the potent anticancer agent taxol were carried out in order to gain an understanding of the chemical reactivity of the drug and the factors which contribute to its biological activity. The C-2' and/or the C-7 hydroxyl groups of taxol were substituted with acetyl, ßalanyl, silyl, succinyl, trichloroethyloxycarbonyl or carbonate linked dibenzylidene protected glucosyl groups. The C-7 position was selectively epimerized under free radical conditions and a 2'-epiacetyltaxol was produced via base catalysed epimerization. The C-2' amide became nucleophilic in the presence of base an
APA, Harvard, Vancouver, ISO, and other styles
7

Vervoort, Hélène C. "Novel anticancer agents from Ascidiacea /." Diss., Connect to a 24 p. preview or request complete full text in PDF format. Access restricted to UC campuses, 1999. http://wwwlib.umi.com/cr/ucsd/fullcit?p3035904.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kuder, Craig Heath. "Schweinfurthins as novel anticancer agents." Diss., University of Iowa, 2009. https://ir.uiowa.edu/etd/840.

Full text
Abstract:
Several members of the schweinfurthin family are potent and selective inhibitors of cancer cell growth in the NCI 60-cell cancer screen. The schweinfurthins display unique activity in this screen which suggests that these compounds have a previously unexploited target. This activity encourages development of the schweinfurthins as anti-cancer agents; however, the scarcity of the natural products has hindered biological evaluation. For this reason, a program was initiated to synthesize the natural products and analogues thereof. These efforts have made 5 natural product schweinfurthins and over
APA, Harvard, Vancouver, ISO, and other styles
9

Gandin, Valentina. "Metal complexes as potential anticancer agents." Doctoral thesis, Università degli studi di Padova, 2009. http://hdl.handle.net/11577/3426115.

Full text
Abstract:
Metal-based antitumor drugs play a relevant role in antiblastic chemotherapy. Cisplatin is regarded as one of the most effective drugs, even if severe toxicities and drug resistance phenomena limit its clinical use. Therefore, in recent years there has been a rapid expansion in research and development of novel metal-based anticancer drugs to improve clinical effectiveness, to reduce general toxicity and to broaden the spectrum of activity. The variety of metal ion functions in biology has stimulated the development of new metallodrugs other than Pt drugs with the aim to obtain compounds acti
APA, Harvard, Vancouver, ISO, and other styles
10

Pan, Ende. "Searching for Anticancer Agents and Antimalarial Agents from Madagascar." Diss., Virginia Tech, 2010. http://hdl.handle.net/10919/77260.

Full text
Abstract:
In our continuing search for biologically active natural products from Madagascar as part of an International Cooperative Biodiversity Group (ICBG) program, a total of four antiproliferative extracts were studied, leading to the isolation of twelve novel compounds with antiproliferative activity against the A2780 human ovarian cancer line, and one extract with antimalarial activities was studied, which led to the isolation of five new natural products with antimalarial activities against the Dd2 and HB3 malarial parasites. The plants and their metabolites are discussed in the following order:
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Agenți anticancer"

1

Ojima, Iwao, Gregory D. Vite, and Karl-Heinz Altmann, eds. Anticancer Agents. American Chemical Society, 2001. http://dx.doi.org/10.1021/bk-2001-0796.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Georg, Gunda I., Thomas T. Chen, Iwao Ojima, and Dolatrai M. Vyas, eds. Taxane Anticancer Agents. American Chemical Society, 1994. http://dx.doi.org/10.1021/bk-1995-0583.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Casini, Angela, Anne Vessières, and Samuel M. Meier-Menches, eds. Metal-based Anticancer Agents. Royal Society of Chemistry, 2019. http://dx.doi.org/10.1039/9781788016452.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Károly, Lapis, Eckhardt S, and International Union Against Cancer, eds. Anticancer drug research. Akadémiai Kiadó, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

L, Cragg Gordon M., Kingston David, and Newman David J, eds. Anticancer agents from natural products. Taylor & Francis, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

National Cancer Institute (U.S.), ed. Fact sheets on anticancer drugs. National Cancer Institute, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Convention, United States Pharmacopeial. Fact sheets on anticancer drugs. National Cancer Institute [distributor], 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

1945-, Ojima Iwao, Vite Gregory D, Altmann Karl-Heinz, American Chemical Society. Division of Organic Chemistry, American Chemical Society. Division of Medicinal Chemistry, and American Chemical Society Meeting, eds. Anticancer agents: Frontiers in cancer chemotherapy. American Chemical Society, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

William, Lown J., ed. Anthracycline and anthracenedione-based anticancer agents. Elsevier, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Thurston, David E. Chemistry and pharmacology of anticancer drugs. Taylor & Francis, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Agenți anticancer"

1

Sausville, E. A., J. I. Johnson, G. M. Cragg, and S. Decker. "Cancer Drug Discovery and Development: New Paradigms for a New Millennium." In Anticancer Agents. American Chemical Society, 2001. http://dx.doi.org/10.1021/bk-2001-0796.ch001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pettit, George R. "Evolutionary Biosynthesis of Anticancer Drugs." In Anticancer Agents. American Chemical Society, 2001. http://dx.doi.org/10.1021/bk-2001-0796.ch002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kadow, John F., Thomas Alstadt, Shu-Hui Chen, et al. "Some Recent Developments in the Synthesis and Structure-Activity Relationship of Novel Taxanes." In Anticancer Agents. American Chemical Society, 2001. http://dx.doi.org/10.1021/bk-2001-0796.ch003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ojima, Iwao, Scott D. Kuduk, Subrata Chakravarty, et al. "New Generation Taxoids and Hybrids of Microtuble-Stabilizing Anticancer Agents." In Anticancer Agents. American Chemical Society, 2001. http://dx.doi.org/10.1021/bk-2001-0796.ch004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Horwitz, Susan Band, Laura A. Martello, Chia-Ping H. Yang, Amos B. Smith, and Hayley M. McDaid. "Discodermolide and Taxol: A Synergistic Drug Combination in Human Carcinoma Cell Lines." In Anticancer Agents. American Chemical Society, 2001. http://dx.doi.org/10.1021/bk-2001-0796.ch005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Vite, Gregory D., Robert M. Borzilleri, Soong-Hoon Kim, Alicia Regueiro-Ren, W. Griffith Humphreys, and Francis Y. F. Lee. "Highly Efficient Semisynthesis of Biologically Active Epothilone Derivatives." In Anticancer Agents. American Chemical Society, 2001. http://dx.doi.org/10.1021/bk-2001-0796.ch006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Altmann, Karl-Heinz, Marcel J. J. Blommers, Giorgio Caravatti, et al. "Synthetic and Semisynthetic Analogs of Epothilones: Chemistry and Biological Activity." In Anticancer Agents. American Chemical Society, 2001. http://dx.doi.org/10.1021/bk-2001-0796.ch007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Klar, Ulrich, Werner Skuballa, Bernd Buchmann, et al. "Synthesis and Biological Activity of Epothilones." In Anticancer Agents. American Chemical Society, 2001. http://dx.doi.org/10.1021/bk-2001-0796.ch008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Winssinger, Nicolas, and K. C. Nicolaou. "Epothilones and Sarcodictyins: From Combinatorial Libraries to Designed Analogs." In Anticancer Agents. American Chemical Society, 2001. http://dx.doi.org/10.1021/bk-2001-0796.ch009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Shih, Chuan, Rima S. Al-Awar, Andrew H. Fray, et al. "Synthesis and Structure-Activity Relationship Studies of Cryptophycins: A Novel Class of Potent Antimitotic Antitumor Depsipeptides." In Anticancer Agents. American Chemical Society, 2001. http://dx.doi.org/10.1021/bk-2001-0796.ch010.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Agenți anticancer"

1

Zhukovets, T. A., M. А. Khancheuski, I. V. Koktysh, E. I. Kvasyuk, and A. G. Sysa. "ANTIOXIDANT EFFECTS OF EMOXYPINE AS ADJUVANT OF ANTI-CANCER DRUGS." In SAKHAROV READINGS 2021: ENVIRONMENTAL PROBLEMS OF THE XXI CENTURY. International Sakharov Environmental Institute of Belarusian State University, 2021. http://dx.doi.org/10.46646/sakh-2021-2-52-55.

Full text
Abstract:
Antioxidants are known to minimize oxidative stress by interacting with free radicals produced as a result of cell aerobic reactions. Oxidative stress has long been linked to many diseases, especially tumours. Therefore, antioxidants play a crucial role in the prevention or management of free radical-related diseases. However, most of these antioxidants have anticancer effects only if taken in large doses. Therefore, the combined use of antioxidants with chemotherapeutic agents is an attractive strategy to combat various tumours. This article focuses on the antioxidant effect of emoxypine. The
APA, Harvard, Vancouver, ISO, and other styles
2

Čolović, Mirjana B., Jelena J. Žakula, Lela B. Korićanac, Nada Savić, Tatjana Parac-Vogt, and Danijela Z. Krstić. "In vitro cytotoxic activity of a monolacunary Wells-Dawson nanocluster against cervical carcinoma HeLa cells." In 2nd International Conference on Chemo and Bioinformatics. Institute for Information Technologies, University of Kragujevac, 2023. http://dx.doi.org/10.46793/iccbi23.415c.

Full text
Abstract:
The aim of this study was to assess in vitro cytotoxic activity of a monolacunary Wells-Dawson nanocluster, α2-K10P2W17O61.20H2O (lacunary WD) against cervical carcinoma HeLa cells as a commonly used model system for the evaluation of antitumor properties. After HeLa cells had been exposed to the investigated polyoxotungstate (the concentration range of 0.001 – 1 mM) for 24, 48, and 72 h, relative cell viability (expressed as a percentage of control) was determined. The obtained results showed that lacunary WD affected HeLa cell viability in a concentration-and time-dependent manner. IC50 valu
APA, Harvard, Vancouver, ISO, and other styles
3

Warsito, Warsito, Masruri Masruri, Sinta Murlistyarini, Dwika Putri Pangesti, and Asyfariatus Zulfa Azhar. "Screening Multitarget Anticancer Compounds from Salicylic Acid Derivatives: (Without and with Amino Acid Linkage) by <i>In Silico</i> Docking." In International Conference on Chemistry and Material Sciences 2023 (IC2MS). Trans Tech Publications Ltd, 2024. http://dx.doi.org/10.4028/p-svkm5p.

Full text
Abstract:
This research aims to design anticancer molecules using the hybridization concept based on molecular derivatives of salicylic acid. The investigation explores structures with and without linked amino acid alanine through an in-silico docking approach. The research conducts screenings of the designed salicylic acid derivative molecules against receptors, including MMP9, MMP2, CDK2, P53, BAK EGFR, and ADP Ribose Polymerase. The most promising docking results for multitarget cancer compounds were observed in salicylic acid derivatives with amino acid linkages, specifically salicylic acid-curcumin
APA, Harvard, Vancouver, ISO, and other styles
4

Satya, Kulsum Hashmi, Sakshi Gupta, Armeen Siddique, and Seema Joshi. "Vanadium Complexes as Potential Anticancer Agents." In ASEC 2023. MDPI, 2023. http://dx.doi.org/10.3390/asec2023-15263.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jovičić Milić, Sandra S., Marko Antonijević, Đorđe S. Petrović, Verica V. Jevtić, and Danijela Lj Stojković. "Investigation of the anticancer activity of 2-amino-6-methylbenzothiazole and corresponding Pd(II) complex using molecular docking simulations." In 2nd International Conference on Chemo and Bioinformatics. Institute for Information Technologies, University of Kragujevac, 2023. http://dx.doi.org/10.46793/iccbi23.535jm.

Full text
Abstract:
In our prior investigations, it has been established that compound di(2-amino-6-methylbenzothiazole)dichloridopalladate(II) (C1) exhibits promising efficacy in inhibiting the growth of colon carcinoma, thereby demonstrating potential as an anticancer agent. To elucidate the underlying mechanism of action against cancer, a comprehensive investigation involving DNA binding analysis and a series of assays to evaluate the inhibitory potential of compound C1 against key proteins involved in cancer metabolism were conducted. The significant inhibitory potential of C1 towards Bcl-2, Ki-67, and CDK-4
APA, Harvard, Vancouver, ISO, and other styles
6

Kuttikrishnan, Shilpa, Kirti S. Prabhu, Tamam Elimat, et al. "Anticancer Activity of Neosetophomone B, An Aquatic Fungal Secondary Metabolite, Against Hematological Malignancie S." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0106.

Full text
Abstract:
Cancer is one of the most life threatening diseases, causing nearly 13% death in the worldwide. Leukemia, cancer of the hematopoetic cells is the main cause of cancer death in adults and children. Therapeutic agents used in treatment of cancer are known to have narrow therapeutic window and tendency to develop resistance against some cancer cell lines thus, proposing a need to discover some novel agents to treat cancer. In the present study we investigated the anticancer activity of Neosetophomone B(NSP-B), an aquatic fungal metabolite isolated from Neosetophoma sp against leukemic cells (K562
APA, Harvard, Vancouver, ISO, and other styles
7

Antonijevic, Marko, Jelena Đorovic Jovanovic, Ana Kesic, Dejan Milenkovic та Zoran Markovic. "КOMPLEKSI ZLATA KAO POTENCIJALNI SUPLEMENTI SA ANTIKANCEROGENIM I ANTIVIRUSNIM DELOVANJEM". У XXVI savetovanje o biotehnologiji sa međunarodnim učešćem. University of Kragujevac, Faculty of Agronomy, 2021. http://dx.doi.org/10.46793/sbt26.429a.

Full text
Abstract:
The pharmacologic properties of gold compounds have been known since the end of the 19th century. They have been used for different studies, even though they are usually used for the treatment of arthritis. In the last decade, gold complexes have received increased attention due to the variety of their applications. Primary, they have been investigated as potential anticancer and chemotherapeutic agents. It is well known that gold(III) complexes are very similar to platinum(II) compounds, so they could exhibit prospective anticancer, cytotoxic and antitumor properties. In this paper, were inve
APA, Harvard, Vancouver, ISO, and other styles
8

Amaravadi, Ravi K. "Abstract SY01-04: Chloroquine derivatives as anticancer agents." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-sy01-04.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mihigo, Helene, and Isabel Rozas. "Guanidinium-like protein kinase inhibitors as anticancer agents." In 6th International Electronic Conference on Medicinal Chemistry. MDPI, 2020. http://dx.doi.org/10.3390/ecmc2020-07508.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Chen, Thomas C., Axel H. Schonthal, and Florence H. Hofman. "Abstract B77: Perillyl alcohol derivatives as anticancer agents." In Abstracts: AACR International Conference held in cooperation with the Latin American Cooperative Oncology Group (LACOG) on Translational Cancer Medicine; May 4-6, 2017; São Paulo, Brazil. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1557-3265.tcm17-b77.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Agenți anticancer"

1

Inoue, Takashi, and Mamoru Narukawa. Anti-tumor efficacy of anti-PD-1/PD-L1 antibodies in combination with other anticancer drugs in solid tumors: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.10.0004.

Full text
Abstract:
Review question / Objective: The aim of this systematic review is to compare the combination of PD-1/PD-L1 inhibitors plus other anticancer drugs and monotherapies of PD-1/PD-L1 inhibitors in terms of antitumor efficacy in the solid tumors to better inform clinical practice. To this end, the proposed systematic review will address the following question: Which is the best choice to enhance response rate in subjects with solid tumors, PD-1/PD-L1 inhibitors plus cytotoxic agents or PD-1/PD-L1 inhibitors plus other targeted anticancer drugs? Condition being studied: Cancer is the leading cause of
APA, Harvard, Vancouver, ISO, and other styles
2

Lee, Anthony J. Studies on the Novel Anticancer Agents Metabolically Formed form 17-Beta-Estradiol. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada430564.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lee, Anthony J. Studies on the Novel Anticancer Agents Metabolically Formed from 17-Beta-Estradiol. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada418901.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Campbell, Colin R. Molecular Determinants of Cellular Sensitivity to Flavopiridol, an Anti-Cell Signaling Anticancer Agent. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada403376.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Campbell, Colin R. Molecular Determinants of Cellular Sensitivity to Flavopiridol an Anti-Cell Signaling Anticancer Agent. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada422275.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Campbell, Colin R. Molecular Determinants of Cellular Sensitivity to Flavopiridol, and Anti-Cell Signaling Anticancer Agent. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada392588.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Seto, Christopher T. Anticancer Agents Based on a New Class of Transition- State Analog Inhibitors for Serine and Cysteine Proteases. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada377205.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Seto, Christopher. Anticancer Agents Based on a New Class of Transition-State Analog Inhibitors for Serine and Cysteine Proteases. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada383963.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Dyakova, Lora, Tanya Zhivkova, Rossen Spasov, Reni Kalfin, and Radostina Alexandrova. Disulfiram as a New Potential Anticancer Agent – Influence on Viability and Proliferation of Virus-transformed Tumour Cells. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, 2019. http://dx.doi.org/10.7546/crabs.2019.11.14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Annunziato, Dominick. HPLC Sample Prep and Extraction SOP v1.3 for Fungi. MagicMyco, 2023. http://dx.doi.org/10.61073/sopv1.3.08.11.2023.

Full text
Abstract:
medicine, industry, and biotechnology. Fungi produce a wide range of bioactive compounds, such as alkaloids, antibiotics, antifungals, immunomodulators, anticancer agents, enzymes, and vitamins. However, these compounds are often locked inside the fungal cell wall, which is composed of chitin, a tough substance that is dif�icult to digest by humans1. Therefore, it is essential to have a good extraction technique that can break down the chitin and release the valuable compounds from the fungi, this is especially essential in the laboratory for accurate lab assays and potency determination durin
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!